Dr. Jeffrey Gold discusses early treatment and ways to limit the spread of seasonal illnesses Rural Health Matters: Preparing for Respiratory Virus Season Dr. Jeffrey Gold discusses early treatment and ways to limit the spread of seasonal illnesses OMAHA, Neb.
The introduction of the respiratory syncytial virus (RSV) vaccine RSVpreF (Abrysvo) for pregnant women and the long-acting monoclonal antibody nirsevimab (Beyfortus) for newborns in 2023 offered protection for infants against the ubiquitous virus. RSV is responsible for 3.6 million hospitalizations and about…
Among infants younger than 12 months in Finland, the implementation of a nationwide nirsevimab immunisation programme was associated with reductions in the incidence of acute otitis media and in respiratory syncytial virus (RSV) detections, with the greatest decreases observed among infants…
Transmission of vaccine-strain rotavirus was uncommon and had no clinical consequences in a US neonatal intensive care unit (NICU) that routinely administers the live pentavalent (five-strain; RV5) rotavirus vaccine, a report published yesterday in Pediatrics suggests. Rotavirus infects the intestinal lining,…
Funding will increase enrollment of children as young as 12 months old and explore the potential for BLB201 to reduce RSV transmissionATHENS, Ga. and SAN JOSE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus…
(StatePoint) Respiratory syncytial virus, or RSV, infects people of all ages, however, it can be dangerous for babies and some young children. As many as 80,000 children under 5 in the United States are hospitalized each year due to the disease. Fortunately,…
Investigational agent Zelicapavir cut time to complete RSV symptom resolution by up to a week and lowered hospitalization in high-risk adults. RSVHR (NCT05568706) randomly assigned 186 symptomatic adults with RSV to zelicapavir (n = 121) or placebo (n = 65) once daily for five days.¹ Patients…
Manitobans aged 80 and older who qualify for a free respiratory syncytial virus (RSV) vaccine cannot currently receive it at pharmacies, leaving some seniors looking for other options to access the immunization. The provincial program took effect Oct. 1, expanding access to…
Sep 08, 2026, 08:00 ET To learn more about BEYFORTUS and serious RSV lung infection prevention, visit BEYFORTUS.com. Parents are encouraged to talk with their baby's doctor to understand if BEYFORTUS is right for their child. Keke Palmer is a paid spokesperson…
— A multiseason analysis reveals an unexpectedly increased risk of death after hospital discharge WASHINGTON -- Nearly one in 10 adults hospitalized with respiratory syncytial virus (RSV) infection died in the hospital or within 30 days of discharge, according to a CDC analysis of…
Respiratory syncytial virus in babies and older adults: cases, hospital pressure and new protections such as nirsevimab.
An article joins this feed when it matches these terms. Each one is also a search of its own.